Leveraging our proprietary OPA core technology platform, Serilink has developed a comprehensive platform-based development system. This system enables the large-scale, stable production of a variety of plug-and-play OPA reagent kit products, including OPA-fluorescence, OPA-PEG, OPA-toxin, OPA-polymer, OPA-Click chemistry, and more.
Our platform-based development system allows us to better meet the diverse needs of researchers by offering standardized reagent kits. Additionally, we provide customized laboratory products and services tailored to customer requirements, supporting the domestic replacement of imports and aiding the development of the biopharmaceutical research sector.
With our proprietary patent technology, we ensure that we can meet the needs of researchers and further provide commercial R&D services to businesses.
Our reagent kit products primarily serve research institutions, including biological laboratories in higher education institutions, life sciences, medical research organizations, central laboratories in hospitals and clinics, as well as pharmaceutical companies and biotechnology firms.
Our products are mainly used in chemical research, new drug development, gene-engineered drugs, cell-engineered drugs, and diagnostic reagents. Applications include protein labeling, molecular immobilization, peptide/protein modification, and fluorescence tagging.
Utilizing our robust research capabilities and expert knowledge, combined with our own intellectual property, we assist customers in developing and manufacturing innovative derivatives such as PEGs, ADCs, PDCs, and radionuclides. We are committed to providing the best services and products in the shortest possible time according to customer needs.